Post-approval Follow-up Study of the IC-8 Apthera Intraocular Lens (IOL)
Post-approval Follow-up Study of the IC-8 Apthera IOL
Sponsor: AcuFocus, Inc.
Listed as NCT05758883, this observational or N/A phase trial focuses on Cataract and Presbyopia and remains completed. Sponsored by AcuFocus, Inc., it has been updated 8 times since 2023, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
8 versions recorded-
Sep 2025 — Present [monthly]
Completed
-
Sep 2024 — Sep 2025 [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
May 2024 — Jul 2024 [monthly]
Completed
Status: Enrolling By Invitation → Completed
-
Mar 2024 — May 2024 [monthly]
Enrolling By Invitation
▶ Show 3 earlier versions
-
Dec 2023 — Mar 2024 [monthly]
Enrolling By Invitation
Status: Recruiting → Enrolling By Invitation
-
Jun 2023 — Dec 2023 [monthly]
Recruiting
-
Apr 2023 — Jun 2023 [monthly]
Recruiting
First recorded
Jan 2023
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- AcuFocus, Inc.
For direct contact, visit the study record on ClinicalTrials.gov .